Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT05590702
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18-year old
* CLL or SLL requiring a therapeutic strategy according to iwCLL criteria or investigator evaluation
* Patient requiring therapy for immune events (autoimmune Thrombocytopenia and autoimmune hemolytic anemia) are eligible
* Patients who have been informed verbally and in writing about this study, and who do not object to their data being electronically processed or subjected to data quality control
* All consecutive patients for whom a discussion in the setting of local or regional multidisciplinary collegial meeting (in french : réunion de concertation pluridisciplinaire / RCP) has retained the need for starting a therapeutic strategy (curative or palliative)
* Patients with untreated or previously treated CLL/SLL are both eligible
* Patients enrolled in a clinical trial can be included in this non-interventional cohort study
* Patients requiring therapy for CLL/SLL-associated immune events only are also eligible
Exclusion Criteria:
* Patients with no need of therapy
* Patients with asymptomatic Binet A CLL
* Patient with Richter's syndrome at inclusion
* Patient requiring immunoglobulin substitution (with no need of a more specific therapy)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05590702
Study Brief:
Protocol Section:
NCT05590702